Literature DB >> 8864901

Osteochondrogenic potential of marrow mesenchymal progenitor cells exposed to TGF-beta 1 or PDGF-BB as assayed in vivo and in vitro.

P Cassiede1, J E Dennis, F Ma, A I Caplan.   

Abstract

Mesenchymal progenitors cells can be isolated from rat bone marrow and mitotically expanded in vitro. When these cells, which we operationally call mesenchymal stem cells (MSCs), are placed in an appropriate environment, they have the capacity to differentiate into bone and/or cartilage. This capacity is called osteochondrogenic potential. In this study, preconfluent MSCs were exposed in vitro to 5 ng/ml transforming growth factor-beta 1 (TGF-beta 1) or platelet-derived growth factor, isoform BB (PDGF-BB) for a pulse of 48 h and assayed for cell proliferation, alkaline phosphatase activity, and osteochondrogenic potential; untreated MSC's served as controls. In these cell culture conditions, TGF-beta 1 or PDGF-BB had similar effects on proliferation and alkaline phosphatase activity. Both growth factors increased cell proliferation and decreased alkaline phosphatase activity of MSCs. Sister cultures of TGF-beta 1- or PDGF-BB-treated MSCs and untreated MSCs were trypsinized. For each type of culture, the trypsinised MSCs were split in two parts: one part was replated in an osteogenic medium to assess its in vitro osteogenic potential, whereas the other part was seeded into porous calcium phosphate ceramics and implanted subcutaneously in syngeneic rats to assess its in vivo osteochondrogenic potential. PDGF-pretreated MSCs showed no difference in in vivo and in vitro osteochondrogenesis from that of control MSCs, while TGF-beta 1 pretreatment blocked the osteochondrogenic potential of MSCs when assayed in vitro for bone nodule formation. However, when tested in vivo, TGF-beta 1-pretreated MSCs were able to form bone and cartilage. These data show that measurements of proliferation and alkaline phosphatase activity of preconfluent MSCs immediately after exposure to growth factor were not predictive of their subsequent osteochondrogenic potential. Moreover, the variation of the osteochondrogenic potential of MSCs after exposure to growth factor was further modulated by the environment in which the MSCs were assayed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8864901     DOI: 10.1002/jbmr.5650110911

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  22 in total

Review 1.  Artificial cell microencapsulated stem cells in regenerative medicine, tissue engineering and cell therapy.

Authors:  Zun Chang Liu; Thomas Ming Swi Chang
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

Review 2.  Consequences of irradiation on bone and marrow phenotypes, and its relation to disruption of hematopoietic precursors.

Authors:  Danielle E Green; Clinton T Rubin
Journal:  Bone       Date:  2014-03-05       Impact factor: 4.398

3.  Advances in Tissue Engineering Techniques for Articular Cartilage Repair.

Authors:  A M Haleem; C R Chu
Journal:  Oper Tech Orthop       Date:  2010-06

4.  Physical interaction of CCN2 with diverse growth factors involved in chondrocyte differentiation during endochondral ossification.

Authors:  Hany Mohamed Khattab; Eriko Aoyama; Satoshi Kubota; Masaharu Takigawa
Journal:  J Cell Commun Signal       Date:  2015-04-19       Impact factor: 5.782

Review 5.  Design and characterization of calcium phosphate ceramic scaffolds for bone tissue engineering.

Authors:  Isabelle Denry; Liisa T Kuhn
Journal:  Dent Mater       Date:  2015-09-28       Impact factor: 5.304

6.  Isolation and perivascular localization of mesenchymal stem cells from mouse brain.

Authors:  Seok-Gu Kang; Naoki Shinojima; Anwar Hossain; Joy Gumin; Raymund L Yong; Howard Colman; Frank Marini; Michael Andreeff; Frederick F Lang
Journal:  Neurosurgery       Date:  2010-09       Impact factor: 4.654

7.  Mesenchymal stem cells display tumor-specific tropism in an RCAS/Ntv-a glioma model.

Authors:  Tiffany Doucette; Ganesh Rao; Yuhui Yang; Joy Gumin; Naoki Shinojima; B Nebiyou Bekele; Wei Qiao; Wei Zhang; Frederick F Lang
Journal:  Neoplasia       Date:  2011-08       Impact factor: 5.715

8.  The effectiveness of bone mineral density as supplementary tool for evaluation of the osteogenic potential in patients with spinal fusion.

Authors:  Byung-Hak Kim; Heun-Guyn Jung; Kyung-Ho Park; Dae-Hee Kim; Yong-Soo Choi
Journal:  Asian Spine J       Date:  2009-06-30

9.  Integral role of platelet-derived growth factor in mediating transforming growth factor-β1-dependent mesenchymal stem cell stiffening.

Authors:  Deepraj Ghosh; Loukia Lili; Daniel J McGrail; Lilya V Matyunina; John F McDonald; Michelle R Dawson
Journal:  Stem Cells Dev       Date:  2013-11-08       Impact factor: 3.272

10.  Effects of platelet-poor plasma, platelet-rich plasma, and platelet-rich fibrin on healing of extraction sockets with buccal dehiscence in dogs.

Authors:  Ichiro Hatakeyama; Eriko Marukawa; Yukinobu Takahashi; Ken Omura
Journal:  Tissue Eng Part A       Date:  2013-11-27       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.